Crandell Keith's Form 4 filing
Boundless Bio, Inc.BOLD · filed Apr 4, 2024
- Accession no.
- 0000950170-24-041842
- Filed
- Apr 4, 2024, 4:30 PM ET
- Trade date
- Apr 2, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 7 derivative transactions. Open-market purchases total $3.20M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crandell KeithCIK 0001219039 | 10% Owner |
| Nelsen RobertCIK 0001219042 | 10% Owner |
| Bybee ClintonCIK 0001219043 | 10% Owner |
| Gillis StevenCIK 0001229592 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | Common Stock | CConversionAcquired | +589,743 | –F1 | – | 617,092 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionAcquired | +787,545 | –F1 | – | 828,570 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionAcquired | +1,048,433 | –F1 | – | 1,048,433 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | PPurchaseAcquired | +66,667 | $16.00 | +$1,066,672 | 683,759 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | PPurchaseAcquired | +133,333 | $16.00 | +$2,133,328 | 1,181,766 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2024 | Common Stock | CConversionDisposed | −424,908 | –F1 | – | 0 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionDisposed | −586,080 | –F1 | – | 0 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionDisposed | −454,212 | –F1 | – | 0 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionDisposed | −227,920 | –F1 | – | 0 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionDisposed | −164,835 | –F1 | – | 0 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionDisposed | −201,465 | –F1 | – | 0 | Indirect | Duplicate filing |
| Apr 2, 2024 | Common Stock | CConversionDisposed | −366,301 | –F1 | – | 0 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
Referenced by the price of 3 transactions in Table I and 7 transactions in Table II.
Remarks
This Form 4 is one of two reports relating to the same transaction being filed jointly by ARCH IX, AVP IX LP, ARCH IX Overage, AVP IX Overage LP, AVP IX LLC, ARCH X Overage, AVP X Overage LP, AVP X LLC, Robert Nelsen, Keith Crandell, Steve Gillis and Clint Bybee (collectively, the "Reporting Persons"). Kristina Burow is filing her own Form 4 separately.